Qureight aims to reduce racial inequalities in lung disease treatment Â
Medical technology company Qureight is working with University Hospitals Birmingham to ensure its AI model for treating IPF reflects a diverse population.
Back to Top
Medical technology company Qureight is working with University Hospitals Birmingham to ensure its AI model for treating IPF reflects a diverse population.
Leeds Teaching Hospitals NHS Trust is collaborating on an AI-powered test that has the potential to speed up the cancer diagnosis process.
AdviseInc has announced it has secured 22 new NHS trust contracts and 61 NHS trust contract renewals since the start of the year.
Great Ormond Street Hospital for Children and Roche UK are co-developing digital tools to better care for children with rare and complex diseases.
Roche UK and Nye Health have partnered to co-create digital solutions that learn and adapt to patients’ needs outside of a traditional clinical setting.
Ultromics has gained FDA Breakthrough Device Designation for its AI-powered EchoGo Amyloidosis platform, which is speeding up diagnosis.